Navigation Links
Suppressing growth hormone in early adulthood may prevent cancer

A modest suppression of growth hormone and related compounds beginning in early adulthood may delay the onset or progression of several types of cancer, researchers from Wake Forest University School of Medicine and other centers reported today at ENDO 2005, the annual meeting of the Endocrine Society, in San Diego.

Suppression of growth hormone and insulin-like growth factor (IGF-1) also may decrease cancer risk in those individuals at high risk for disease, and perhaps could be a preventive measure, said William E. Sonntag. Ph.D., the lead investigator, who based his findings on research in rats.

He said IGF-1 is an important blood-borne factor that increases cell growth and prevents cell death and has been proposed to be a factor in the initiation of cancer.

"Elevated IGF-1 levels in pre-menopausal women have been demonstrated to be a risk factor for breast cancer as well as numerous other cancers," said Sonntag, professor of physiology and pharmacology at the School of Medicine, a part of Wake Forest University Baptist Medical Center.

IGF-1 in the blood also may act as a tumor promoter during the early development of cancer, he said.

Although additional research is needed, he said, drugs in the somatostatin class are currently available to suppress growth hormone and IGF-1 in people, so somatostatin analogs could be given as preventative measures to lower plasma IGF-1 before the onset of disease, especially in high-risk people.

In a previous study, rats with high levels of growth hormone (a circulating factor that increases IGF-1 levels) exhibit an increase in spontaneous mammary tumors. Dwarf animals with 50 percent lower IGF-1 levels do not develop tumors in response to a chemical carcinogen. But Sonntag said that if these dwarf rats are given growth hormone to increase IGF-1 in the blood, tumors develop at the same rate as in the normal animals.

Suppression of IGF-1 activity inhibits the proliferation of numerous cell types and cancers. "IGF-1 levels in the blood can be reduced by low-calorie diets, which could be a mechanism for the diet-cancer relationship," said Sonntag, whose work explores the neurobiology of aging.

Previous studies in some animals indicate that a reduction in IGF-1 activity increases lifespan. To date, there are no studies of a specific suppression of IGF-1 on aging or age-related diseases.

In the current study, Sonntag found that a life-long deficiency of IGF-1 decreased cancer risk by approximately 45 percent and decreased cancer deaths by 12-15 percent.

"Besides reducing the incidence of cancer in these rats, we found that a modest suppression of plasma IGF-1 beginning shortly after puberty and continued throughout life reduces the incidence of kidney disease and increases lifespan," Sonntag said.


'"/>

Source:Wake Forest University Baptist Medical Center


Related biology news :

1. Plants, animals share molecular growth mechanisms
2. U-M scientists find genes that control growth of common skin cancer
3. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
4. Researchers discover chemical compounds that affect plant growth
5. Physical and functional interaction of key cell growth molecules linked to cancer
6. Hormones and growth: The control of body size and developmental growth rate in fruit flies
7. Researchers find molecule that inhibits regrowth of spinal nerve cells
8. Gradient guides nerve growth down spinal cord
9. Scientists discover genetic pathway responsible for breast cancer cell growth
10. Breath of the dragon: ERS-2 and Envisat reveal impact of economic growth on Chinas air quality
11. Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has announced ... Market in Retail Sector 2016-2020" report ... Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has ...
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016  Wellcentive today ... Portland, Oregon -based community care ... provide population health analytics, quality reporting and care ... FamilyCare strengthen its team of quality managers, analysts ... to the provider groups serving FamilyCare members. ...
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert ... years, continues today to pursue the highest level of accuracy and quality with ... AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and tough enough for ...
(Date:2/10/2016)... 10, 2016  The Maryland House of Delegates and ... that University of Maryland School of Medicine Dean ... of Maryland Medical System President and CEO Robert ... the highest honor given to the public by the ... Dean Reece and Mr. Chrencik for their contributions ...
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... that Brent Saunders , Allergan,s CEO and President, ... fireside chat session at the RBC Capital Markets Healthcare ... ET at The New York Palace Hotel in ... be webcast live and can be accessed on Allergan,s ...
Breaking Biology Technology: